Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis

被引:92
作者
Armamento-Villareal, Reina [1 ]
Napoli, Nicola
Panwar, Vinita
Novack, Deborah
机构
[1] Washington Univ, Sch Med, St Louis, MO 63110 USA
[2] St Lukes Hosp, St Louis, MO 63017 USA
关键词
D O I
10.1056/NEJMc062268
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
引用
收藏
页码:2048 / 2050
页数:3
相关论文
共 5 条
[1]
Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].
Bone, HG ;
Hosking, D ;
Devogelaer, J ;
Tucci, JR ;
Emkey, RD ;
Tonino, RP ;
Rodriguez-Portales, JA ;
Downs, RW ;
Gupta, J ;
Santora, AC ;
Liberman, UA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199
[2]
Severely suppressed bone turnover: A potential complication of alendronate therapy [J].
Odvina, CV ;
Zerwekh, JE ;
Rao, DS ;
Maalouf, N ;
Gottschalk, FA ;
Pak, CYC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1294-1301
[3]
Editorial: Long-term safety of bisphosphonates [J].
Ott, SM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1897-1899
[4]
Postmenopausal osteoporosis [J].
Rosen, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (06) :595-603
[5]
Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases [J].
Ruggiero, SL ;
Mehrotra, B ;
Rosenberg, TJ ;
Engroff, SL .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 62 (05) :527-534